The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sukhtian Faisal Ghiath since 2020.
This trader's CIK number is 1716033.
At the time of last reporting, Sukhtian Faisal Ghiath was the Director of Outlook Therapeutics, Inc.. (stock ticker symbol OTLK).
Also see all insider trading activities at Outlook Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | OTLK | 28,000 | $43,400 | 0 | $0 | 0 | $0 |
| 2020 | OTLK | 10,000 | $6,730 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-02 | OTLK | Buy | 18,000 | 1.40 | 25,200 |
| 2021-04-19 | OTLK | Buy | 10,000 | 1.82 | 18,200 |
| 2020-09-17 | OTLK | Buy | 10,000 | .67 | 6,730 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sukhtian Faisal Ghiath (Director of Outlook Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.